| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.31 |
3e-09 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-08 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.3 |
2e-07 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
| mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.2 |
5e-06 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
7e-06 |